Position in ROIV
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$13,850
+$2,523 QoQ
Shares Held
500
-4.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Avion Wealth holds $237,935 across 65 Biotechnology names. ROIV ranks #5 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
24 | $18,543 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
39 | $17,415 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
48 | $15,881 | |
| 4 | KOD |
Kodiak Sciences Inc.
|
411 | $15,667 | |
| 5 | ROIV |
Roivant Sciences Ltd.
This page
|
500 | $13,850 | |
| 6 | EXEL |
Exelixis, Inc.
|
260 | $11,151 | |
| 7 | MRNA |
Moderna, Inc.
|
189 | $9,601 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
153 | $9,593 |
All Filings in ROIV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,850 | 500 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $11,327 | 522 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $7,565 | 500 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $5,635 | 500 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $5,045 | 500 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $5,915 | 500 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $5,770 | 500 | Shares | Sole | 2024-10-18 | |
| No filing history on record for this holder in this stock. | ||||||